Relationship between Target Cell Cytotoxicity and Activation |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
CD8+ T-cell responses play an important role in the clearance
of respiratory virus infection, but may also contribute to lung injury in the process. The effector mechanisms involved in viral clearance and associated lung injury include both cytolytic
and noncytolytic effector functions. Previously we have shown
that CD8+ T-cell recognition of alveolar epithelial cells triggers chemokine expression by the epithelial cell and that this
plays an important role in the inflammatory infiltration that
ensues in the context of T cell-mediated injury (Zhao and colleagues, J. Clin. Invest. 2000;106:R49-R58). In the present study
we sought to understand the relationship between alveolar
cell cytotoxicity and chemokine expression, both of which occur as a result of CD8+ T-cell antigen recognition. Alveolar epithelial cells efficiently process and present overlapping viral
epitopes, and CD8+ T-cell recognition of these class I major
histocompatibility complex-restricted epitopes resulted in cytotoxicity of the alveolar cells by both wild-type and perforin-deficient T cells. However, the contribution of perforin-mediated lysis to the total cytotoxicity of alveolar cells by CD8+ T
cells was minimal, and the majority of the lysis was attributable
to tumor necrosis factor-
expressed by the T cell. CD8+ T-cell
recognition also led to activation of nuclear factor-
B in the
alveolar epithelial target cells, at levels inversely proportional to
the effector/target (E:T) ratio. Finally, at varying E:T ratios, we
demonstrated an inverse relationship between alveolar cell cytotoxicity and monocyte chemotactic protein-1 expression, both of which occur as a result of T-cell recognition. These
findings may have important ramifications in understanding
the relationship between viral clearance and lung injury.
| |
Introduction |
|---|
|
|
|---|
Respiratory virus infection evokes potent immune responses in the lung, involving various arms of the innate
and adaptive immune system. CD8+ T cells are particularly important in clearance of virus, but may also contribute to lung injury in the process (1), although the relative contribution of the virus infection itself and the T-cell
antiviral effector activities in this context are unclear. The
effector mechanisms involved in viral clearance and associated injury include both cytolytic and noncytolytic effector functions (5, 6). CD8+ T cells accumulate in the lung
parenchyma in a variety of inflammatory disease states,
but the nature of their specific contribution to lung injury
is also unclear (4). One hypothesis concerning the
pathogenesis of idiopathic interstitial pneumonia suggests
that the immune response to a viral infection may become
quantitatively or qualitatively inappropriate and may lead
to acute and/or chronic lung injury. We used an in vivo
model of interstitial pneumonia to examine the specific effects of CD8+ cytolytic T cells and their various effector
activities on lung injury. We showed that activated antiviral T cells induce significant pulmonary inflammation and
injury after adoptive transfer into transgenic animals expressing a viral antigen on alveolar epithelial cells, and in
the absence of virus infection (5, 6). The injury results in
considerable respiratory dysfunction and eventual death,
in a time frame that is dependent upon cell dose. Alveolar
epithelial cells are uniquely sensitive to the cytotoxic effect of transmembrane tumor necrosis factor (TNF)-
expressed by CD8+ T cells, and are also activated in vitro
and in vivo by CD8+ T-cell recognition to express inflammatory chemokines (5). We demonstrated in vivo that
CD8+ T cell-mediated lung injury occurs in the absence
of perforin and Fas, but neutralizing antibody to TNF-
completely abrogates lung injury that occurs in absence of
both mediators (7). In vitro, alveolar epithelial-derived cells
appear sensitive to the cytotoxic effects of perforin and TNF-
expressed by CD8+ T cells but are completely insensitive to induction of apoptosis by Fas ligand, despite
expression of functional Fas on the alveolar cells (7). These
cells are also significantly less susceptible to cytolysis induced by soluble TNF-
than by TNF-
expressed by T
lymphocytes (7, 8).
CD8+ T cells express predominantly a transmembrane
form of TNF-
(8), which may initiate injury via direct
cytotoxic effects on alveolar epithelial cells. This may contribute to the observed respiratory dysfunction that evolves
in transgenic recipients. However, the inflammatory infiltration that ensues 3 to 4 d after adoptive transfer into hemagglutinin (HA)-transgenic mice consists largely of neutrophils, host lymphocytes, and (predominantly) activated
macrophages; it is the presence of large numbers of these
cells that correlates most strongly with the profound respiratory impairment observed after T-cell transfer (6). We
have also demonstrated that alveolar epithelial cells are
activated in vivo as a result of specific CD8+ T-cell antigen recognition to express the inflammatory chemokine
monocyte chemotactic protein (MCP)-1 (5). This induction appears to be mediated primarily by transmembrane TNF-
expressed on the surface of the antigen-specific
CD8+ T cells, and in vivo neutralization of MCP-1 significantly abrogates the inflammatory infiltration that ensues
after adoptive transfer of the T cells. In this study we sought
to examine the relationship between alveolar epithelial
cell cytotoxicity and activation that occurs as a direct result of CD8+ T-cell recognition of antigen presented by
the epithelial cells. We present evidence that alveolar epithelial cells show considerably greater sensitivity to the cytotoxic effects of transmembrane TNF-
than to perforin
expressed by CD8+ T cells. Further, we show that alveolar epithelial cells may undergo activation or cytolysis as a
result of antigen-specific CD8+ T-cell recognition, but
that these outcomes are inversely related and vary with effector/target (E:T) ratio.
| |
Materials and Methods |
|---|
|
|
|---|
Effector T-Cell Populations
To obtain CD8+ T-cell populations with a defined HA specificity we immunized wild-type BALB/c mice with a recombinant vaccinia virus (vv) expressing an A/Japan/57 HA deletion mutant that lacks the transmembrane and cytoplasmic domain [vv(HAanchor-)]. The construct retains the HA204-212 and HA210-219 epitopes recognized in association with the H-2Kd major histocompatibility complex (MHC) class I molecule by H-2Kd-restricted CD8+ cytotoxic T lymphocytes (CTLs). HA-immune splenocytes from these animals, which contained CD8+ memory T cells specific for these two HA epitopes, were restimulated in vitro with splenocytes infected with the A/GV/17 (H2N2) influenza strain. This virus has a single nucleotide difference in the HA gene (compared with the A/Japan/57 strain) leading to an amino acid substitution in the 204-212 epitope (N-to-K change at residue 207 [6]). Consequently, this virus selectively activates and expands CD8+ memory CTL precursors from the vv(HAanchor-)-primed mice which are directed to the HA 210-219 epitope common to A/GV/17 and A/Japan/57 (6). These populations were maintained by weekly in vitro stimulation in fresh Iscove's complete media supplemented with 10 units/ml of interleukin (IL)-2. The clones were restimulated in vitro with irradiated syngeneic splenocytes that were infected with A/Japan/57 influenza. CD8+ T-cell clones used in these experiments were generated by limiting dilution as previously described (11). The clones were restimulated in vitro with irradiated syngeneic splenocytes that were infected with A/Japan/57 influenza, and placed into fresh Iscove's complete media supplemented with 10 units/ml of IL-2.
T-Cell Cytotoxicity Assay
CD8+ T-cell clones used in these experiments were generated either from wild-type or perforin-deficient mice (12). On Day 5 after in vitro stimulation, T cells were tested for cytolytic activity
using a 51Cr-release assay against target cells infected with A/Japan/57 (multiplicity of infection [MOI} of approximately 100), or
against target cells loaded with 10
9 M synthetic peptide representing either the 204-212 (LYQNVQTYV) or the 210-219 (TYVSVGTSTL) epitope of the A/Japan/57 HA (13, 22). The
target cells used in these assays were MLE-Kd, which are MLE-15 cells (13) stably transfected with the class I MHC molecule H-2Kd (6) or primary type II pneumocytes (see the following section). Cytotoxicity assays were carried out in 96-well plates with
0.2 ml/well for 6 h, after which 0.1 ml was harvested and counted on a
-counter (Isomedic; ICN Biomedicals, Inc., Costa Mesa, CA). In some experiments, anti-TNF-
antisera (IP400; Genzyme,
Boston, MA) was added to wells at a final dilution of 1:100. Percent specific 51Cr release was calculated according to the formula:
(test CPM
spontaneous release CPM)/(total CPM
spontaneous CPM) × 100 where CPM is counts per min. Spontaneous release from targets incubated with media alone was always less
than 10%.
Specific lysis values represent the mean percent specific 51Cr release from four replicate wells. For analysis of MCP-1 expression, parallel plates were set up with unlabeled target cells, and supernatants were assayed for MCP-1 production using a sandwich enzyme-linked immunosorbent assay (ELISA) (Pharmingen, San Diego, CA) in accordance with the manufacturer's instructions.
Primary Type II Pneumocyte Preparation
Primary alveolar type II cells were prepared using a modification of a previously published method (14). Briefly, BALB/c mice were anesthetized and exsanguinated by severing the inferior vena cava and left renal artery. The tracheae were exposed and cannulated, and lungs were perfused with 10 to 20 ml sterile saline via the pulmonary artery until visually free of blood. Dispase (Collaborative Research, Inc., Bedford, MA) was instilled into the lungs via the tracheal catheter, followed by 1% low-melt agarose warmed to 45°C. The lungs were immediately covered with ice and incubated for 2 min to gel the agarose. Lungs were then dissected out, put in a culture tube containing an additional 1 ml of Dispase, and incubated for 45 min at room temperature. Lungs were then transferred to a culture dish containing DNAse I (Sigma, St. Louis, MO) and the tissue was gently teased away from the airways. The cell suspension was successively filtered and then pelleted. Crude cell suspensions were added to culture dishes coated with anti-CD45 and anti-CD32 antibodies (Pharmingen) and incubated for 1 to 2 h. Plates were removed from the incubator and gently "panned" to free settled type II cells, which were resuspended in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS). Purity of the type II cell preparations used for these studies was 92 ± 1% by morphologic criteria (14) and viability determined by trypan blue exclusion after overnight incubation was > 60%. (Purity for more than 100 separate preparations was consistently > 90%.)
Nuclear Factor-
B Reporter Assays
MLE-Kd cells were transiently transfected with a nuclear factor
(NF)-
B-secreted alkaline phosphatase (SEAP) reporter construct (Clontech, La Jolla, CA), or control plasmids using Superfect (Qiagen, Valencia, CA). After transfection with 2 µg of
DNA (in 0.5 ml) for 3 h, cells were then incubated for 48 h in
DMEM with 5% FBS. Cells were harvested, plated in 96-well
plates, and allowed to adhere overnight. T cells and peptide were
then added at varying E:T ratios, or soluble TNF-
was added at
a saturating concentration (10,000 U/ml [7]), and plates were incubated at 37°C for 6 h, after which time supernatants were sampled for analysis. Chemiluminescent substrate (Clontech) was added
according to the manufacturer's instructions, and samples were
assayed on a luminometer (Turner Designs, Sunnyvale, CA).
Statistical Analysis
Significant differences were determined by the Mann-Whitney test. All error bars represent standard deviation.
| |
Results |
|---|
|
|
|---|
Alveolar Epithelial-Derived Cells Efficiently Process and Present Class I MHC-Restricted Overlapping Viral Epitopes
Antiviral CD8+ T lymphocytes represent an important arm of the adaptive immune response to respiratory virus infection (11, 15). Influenza is a virus that primarily infects respiratory epithelial cells, and we have shown that cytolytic effector T cells can efficiently recognize a subdominant Kd-restricted epitope of the A/Japan/57 influenza HA expressed on virus-infected alveolar epithelial- derived cells leading to alveolar cell cytotoxicity (6, 7). This epitope, HA210-219, overlaps with a dominant Kd- restricted epitope, HA204-212, both of which are processed and presented efficiently by nonrespiratory cell lines in vitro (18). To confirm that alveolar epithelial-derived cells were also capable of efficient processing and presentation of both the dominant and subdominant epitopes, MLE-Kd cells were infected with A/Japan/57 influenza and then used as targets for recognition by epitope-specific CD8+ cytolytic T-cell clones. As shown in Figure 1, clones 40-2 (specific for HA210-219) and 14-1 (specific for HA204-212) recognize and lyse influenza-infected MLE-Kd cells with approximately equivalent efficiency. There was no overlap in the recognition pattern of 40-2 and 14-1, as shown in Figure 2, in which MLE-Kd cells were exogenously loaded with synthetic peptide. This also indicates that the pattern of cytolysis shown in Figure 1 represents a valid readout of epitope processing by alveolar epithelial-derived cells. We also tested peptide-dependent cytoxicity of MLE-Kd cells by perforin-deficient CD8+ T-cell clones PKOGV17 and PKOAA57, specific for the HA210-219 and HA204-212 epitopes, respectively. As shown in Figure 2, both of these T cells induce comparable cytotoxicity of MLE-Kd cells, loaded with appropriate peptide. Interestingly, the level of cytolysis of MLE-Kd cells induced by perforin-deficient CD8+ T-cell recognition was only slightly lower than that induced by wild-type T-cell recognition, suggesting that perforin-mediated cytotoxicity may play a relatively minor role in lysis of this particular target cell.
|
|
Cytotoxicity of Alveolar Epithelial Cells by Wild-Type
CD8+ T Cells Is Mediated Primarily by TNF-
Previously we have shown that perforin-independent
CD8+ T cell-mediated cytolysis of alveolar epithelial cells
is independent of Fas/Fas ligand interaction and entirely
dependent upon TNF-
expressed by the T cell (7). We
also showed that acute T cell-mediated lung injury in vivo
is critically dependent upon TNF-
, and is independent of
Fas expression, though there may be a role for Fas in
chronic injury (19). We have also previously shown that anti-TNF-
completely inhibits cytotoxicity of MLE-Kd
cells by the perforin-deficient T-cell clone PKOGV17 (7). As shown in Figure 3, this effect is not unique to this particular T-cell clone, nor is it unique to recognition of the
subdominant HA210-219 epitope. Anti-TNF-
inhibited
all cytotoxicity of MLE-Kd cells by PKOAA57 (specific
for HA204-212). It is interesting to note that this antibody
also inhibited nearly all cytotoxicity of alveolar cells triggered by the wild-type clone 14-1 (also specific for HA204-212), though the level of lysis was still above background
(not shown). These data further demonstrate that MLE-Kd cells are unusually sensitive to one particular T-cell effector activity, i.e., TNF-
, and that this phenotype is not
unique to one particular T-cell clone or unique to recognition of the subdominant Kd-restricted epitope of A/Japan/
57 influenza HA. Further, MLE-Kd cells appear to have a
limited susceptibility to perforin/granzyme-mediated cytolysis, inasmuch as the bulk of cytotoxicity of these cells appears to be mediated by TNF-
, in contrast to lysis of nonrespiratory target cells, which is primarily mediated by the
perforin pathway (3, 12, 20, 21). Previous studies in this
system (22) and others (23) have shown that the sensitivity
to perforin-mediated cytolysis may be directly related to the
avidity of the T-cell receptor (TCR) for the peptide/MHC
on the target cell. Further, these studies suggested that expression of low-avidity ligands on target cells may preferentially trigger perforin-independent cytolysis by the T cell.
In such circumstances, cytotoxicity has been shown to be
FasL-dependent, at least with respect to nonrespiratory target cells (22, 23). Because peptide/MHC complex avidity is
directly related to peptide concentration (24), we characterized the contribution of perforin-dependent lysis to T cell-
mediated cytotoxicity of MLE-Kd cells at varying peptide
concentrations. As shown in Figure 4, cytolysis of MLE-Kd
cells by the wild-type CD8+ T-cell clone 40-2 reached a
plateau level at a peptide concentration of 10
10 M, and
most of the cytolysis was inhibited by anti-TNF-
. At a 10-fold lower peptide concentration (10
11 M), TNF-dependent cytolysis was reduced but still significant (compared
with backgound; P < 0.01), whereas perforin-dependent cytolysis (i.e., residual lysis in the presence of anti-TNF-
) was not different from background levels. At 10
12 M peptide, cytolysis became undetectable (equal to background). These data suggest that MLE-Kd cells are extremely sensitive to T-cell cytotoxicity mediated by TNF-
, and minimally sensitive to perforin/granzyme-mediated cytolysis.
Thus, although the differential threshold for perforin-dependent and -independent cytotoxicity was also in evidence with these target cells, the effector activity associated with higher threshold activation events was mediated
by TNF-
. To confirm that this phenotype is not unique to
the MLE-Kd cell line, we used primary type II cell isolates
as targets of T-cell cytotoxicity, to assess the relative contribution of the two effector mechanisms. As shown in Figure 5, HA+ cells were lysed by both wild-type and perforin-deficient T-cell clones with comparable efficiency.
This suggests that, similar to MLE-Kd cells, primary type II
cells are also insensitive to perforin-mediated cytotoxicity.
|
|
|
CD8+ T-Cell Recognition of Alveolar Epithelial Cells Results in Epithelial Cell Activation
We previously demonstrated that recognition of type II
pneumocytes by CTL may result not only in target cell
apoptosis but also in alveolar cell activation, both in vitro
and in vivo (5). This activation leads to alveolar MCP-1 expression, which contributes to the inflammatory infiltrates
that ensue after CD8+ T-cell transfer in vivo (6). The relative contributions of alveolar cell cytotoxicity and activation to T cell-mediated lung injury in vivo, however, remains unclear. A critical determinant of cytotoxicity in
vitro is the E:T ratio; however, the relationship between
E:T and type II cell activation is unclear. To begin to analyze the relationship between E:T and alveolar cell activation, MLE-Kd cells were transfected with an NF-
B reporter construct before incubation with varying numbers
of CD8+ T cells. As shown in Figure 6, the degree of NF-
B
activation was inversely related to E:T, with the highest
levels seen at 1:1 (P < 0.05 compared with 5:1). Further, at
6 h the level of NF-
B activation at E:T of 1:1 was similar
to the level of activation by soluble TNF-
at a saturating concentration (7). This is consistent with the hypothesis
that activation and cytolysis are competing processes, and
that at the later time point, cytotoxicity limits the availability of viable cells capable of being activated. To further explore the relationship between cytotoxicity and activation
after 6 h of exposure to T cells, MLE-Kd cells were used as
targets of 51Cr-release assays in parallel with ELISA for
MCP-1. We have previously demonstrated that MLE-Kd
cells express MCP-1 upon activation by transmembrane
TNF-
expressed by CD8+ T cells (and also to a much
lesser extent by soluble TNF-
) and that CD8+ T cells
themselves express no MCP-1 (5). As shown in Figure 7,
the inverse relationship between cytolysis and activation of these alveolar epithelial-derived target cells was evident at the extremes of E:T, with very little cytotoxicity,
and maximal MCP-1 expression observed at an E:T of 1:1.
Conversely, MCP-1 expression became nearly undetectable at an E:T of 20:1, and cytotoxicity reached a plateau
level of over 60%.
|
|
| |
Discussion |
|---|
|
|
|---|
Cytolytic CD8+ T cells represent an important arm of the
adaptive immune response to virus infection, though T cell-
mediated virus clearance may be associated with significant
tissue injury (1). The immune response to respiratory virus infection leads to a complex inflammatory cascade in
the lung, which may result in virus clearance, lung injury,
or both. Virus infection of the respiratory epithelium triggers production of inflammatory mediators by the infected
epithelial cells, such as IL-8 (25) and type 1 interferons
(26). This leads to recruitment of cells and mediators of the
innate immune system, and subsequently to those of the adaptive immune response. Epithelial cells which continue
to present viral antigens during this phase become targets
of antigen-specific cytolytic T-cell recognition. Specific
CD8+ T-cell responses may play an even greater role in
virus clearance (and tissue injury) in immune individuals,
inasmuch as the memory CD8+ T-cell response emerges
earlier and more vigorously than does the CD8+ T-cell response in primary virus infection (27, 28). Though specific CD8+ T-cell recognition of a virus-infected target cell
may result in apoptotic death of the infected cell, the complexity of factors which influence susceptibility to cytolysis
are increasingly being appreciated (2, 29). In addition,
ample evidence exists to indicate that numerous soluble
factors may trigger the expression of a variety of inflammatory mediators by respiratory epithelial cells. However, the
specific contribution of lung epithelial cells to the inflammatory milieu which evolves in the context of an immune
response to a respiratory virus infection has been difficult to assess because of the complicating effects of virus infection on epithelial cell activities. In this study we have
shown that CD8+ T-cell recognition of alveolar epithelial
cells leads to cytotoxicity in a manner much more dependent upon TNF-
than upon perforin, even when both effector activities are available. We observed small but significant differences in lysis of alveolar cells triggered by
perforin-deficient versus wild-type CD8+ T cells, indicating a residual role for perforin in alveolar cell cytotoxicity.
These differences are unlikely to represent differences in
the relative avidity of the different T-cell receptors for MHC/peptide complexes because the peptide dose used in
these experiments (10
9 M) was intentionally high enough
to be well within the plateau range of cytotoxicity (100-fold higher than the break point in Figure 4).
Further, we have shown that specific CD8+ T-cell recognition of alveolar epithelial cells, in the absence of virus infection, may induce alveolar cell expression of a variety of inflammatory mediators in vitro and in vivo. The T cell may also produce soluble inflammatory mediators upon specific antigen recognition, and it is possible that both sources of chemokines contribute to the milieu that leads to parenchymal infiltration of host inflammatory cells, and the resultant respiratory embarrassment. Alveolar epithelial target cells may be important participants in the lung injury resulting from CD8+ T-cell recognition, inasmuch as significant macrophage accumulation occurs approximately 72 to 96 h after transfer and the transferred CD8+ T cells become undetectable in the lungs after approximately 48 h (Enelow and associates, unpublished observation). Further, CD8+ T-cell transfer appears to induce a similar degree of respiratory dysfunction in severe combined immunodeficiency mice expressing the HA transgene, which suggests against a critical role of the host lymphocyte component of the parenchymal infiltration (Enelow and coworkers, unpublished observation).
Chemokines are a large family of chemoattractant cytokines that appear to play a major role in the orchestration and amplification of acute and chronic inflammatory
processes, particularly in the lung (32). The induction
of chemokine expression by alveolar epithelial cells appears to be mediated primarily by TNF-
expressed (and/
or secreted) by the CD8+ T cell, a mediator not commonly associated with T-cell effector activity (39). We
have previously demonstrated that MCP-1 expression is
preferentially triggered by transmembrane TNF-
, whereas
macrophage inflammatory protein-2 expression appears to
be triggered preferentially by soluble TNF-
(5). Distinct
effector functions for the two different forms of TNF-
have
been described in several systems and may relate to the
differential engagement of the two TNF receptors (9, 42).
We speculate that activation of alveolar cells by CD8+ T-cell recognition as read out by MCP-1 production and as
read out by NF-
B activation are similar phenomena, at
least to the extent that they are both inversely related to
cytotoxicity. There are many possible triggers for activation of NF-
B, TNF-
being the prototype, but more work
will be necessary to establish a direct link between NF-
B
activation and MCP-1 transcription.
The results presented in this study have been corroborated with several distinct CD8+ T-cell clones, indicating
that the phenomena described are not unique to one T-cell
clone. The activation of alveolar epithelium which occurs
as a result of specific CD8+ T-cell recognition may reflect
either a population effect or an effect of epithelial cells as
individual responders to TCR engagement (or both).
There are two potential mechanisms that might account for MCP-1 production by alveolar epithelial cells upon
specific T-cell recognition, which are not mutually exclusive. The first involves the direct cytolysis of those target
cells whose MHC/peptide complexes engage TCR, by either
perforin or membrane-bound TNF-
(though the contribution of the former appears quite limited) with associated
antigen-dependent T-cell production of soluble TNF-
. The
soluble TNF-
produced might therefore lead to the induction of bystander MCP-1 expression by other target cells, which stochastically did not engage the TCR of a lymphocyte and did not undergo apoptosis. The second possibility
involves the direct ligation of TCR and TNF receptor(s)
on an individual target cell, the result of which may be activation of the engaged target, and induction of chemokine
expression in the target cell. A critical corollary to this hypothesis is that there may be interactions between cytolytic T cells and target cells that may be below threshold for induction of target-cell death, but above threshold for
induction of transcriptional activation. The fact that induction of chemokine expression could occur in a target cell
expressing MHC/peptide complexes that have been engaged by a TCR of a cytolytic CD8+ T cell suggests that
the perforin/granzyme system may sometimes be quantitatively or qualitatively insufficient to induce cytolysis (at
least with respect to alveolar epithelial-derived cells, which are rather insensitive to perforin-mediated cytolysis), or
that other factors may influence target-cell susceptibility
to cytotoxicity. Indeed, we have in vivo evidence that perforin plays a minimal role in the lung injury-mediated
adoptive transfer of wild-type CD8+ T cells, the primary
mediator being TNF-
(Enelow and coworkers, unpublished observation). Further, the threshold for induction of
chemokine expression by transmembrane TNF-
may be
lower than the threshold for induction of apoptosis. The
identification of cellular regulators of protection against
perforin/granzyme-mediated cytotoxicity (29) and TNF-mediated apoptosis (43) suggest potential mechanisms by
which regulation of in vivo susceptibility of target cells to
T cell-mediated cytolysis might occur.
It is likely that multiple mechanisms account for the activation of epithelial cells as a population in response to specific CD8+ T-cell recognition, the net result of which is the production of chemokines by the alveolar cells, which may in turn amplify inflammatory responses in the lung. In our adoptive transfer model, this may contribute to the recruitment of host inflammatory cells, particularly macrophages, into the lung parenchyma, the infiltration of which strongly correlates with the physiologic dysfunction associated with the interstitial pneumonitis, i.e., restrictive mechanics and diminished diffusing capacity (6). The data in this study suggest that alveolar epithelial cells may be active participants in the inflammation and injury associated with CD8+ T-cell recognition of alveolar antigens in the lung, regardless of the influence of virus infection. Further, apoptotic target-cell death is not a necessary outcome of CD8+ cytolytic T-cell antigen recognition, which may instead (or in addition) lead to inflammatory activation of the cell being recognized.
| |
Footnotes |
|---|
Address correspondence to: Richard I. Enelow, Box 800546, University of Virginia Health System, Charlottesville, VA 22908. E-mail: enelow{at}virginia.edu
(Received in original form December 18, 2000 and in revised form May 9, 2001).
Abbreviations: cytotoxic T lymphocyte, CTL; effector/target ratio, E:T ratio; hemagglutinin, HA; monocyte chemotactic protein, MCP; major histocompatibility complex, MHC; nuclear factor, NF; secreted alkaline phosphatase, SEAP; T-cell receptor, TCR; tumor necrosis factor, TNF.Acknowledgments: The authors gratefully acknowledge the statistical advice of Dr. Alfred C. Connors, Department of Health Evaluation Sciences, as well as the technical assistance of Alyssa R. Stell, Jennifer S. Liebermann, and Dana T. Fiedeldey. This work was supported by USPHS grant HL-58660; one author (R.I.E.) is a recipient of a career Investigator Award from the American Lung Association. Support of the Beirne B. Carter Foundation, the American Lung Association of Virginia, and the Cardiovascular Research Center at the University of Virginia is gratefully acknowledged.
| |
References |
|---|
|
|
|---|
1.
Alwan, W. H.,
W. J. Kozlowska, and
P. J. Openshaw.
1994.
Distinct types of
lung disease caused by functional subsets of antiviral T cells.
J. Exp. Med.
179:
81-89
2. Guidotti, L. G., and F. V. Chisari. 1996. To kill or to cure: options in host defense against viral infection. Curr. Opin. Immunol. 8: 478-483 [Medline].
3. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14: 207-232 [Medline].
4. Openshaw, P. J.. 1995. Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin. Immunopathol. 17: 187-201 [Medline].
5. Zhao, M. Q., M. H. Stoler, A. N. Liu, B. Wei, C. Soguero, Y. S. Hahn, and R. I. Enelow. 2000. Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8+ T cell recognition. J. Clin. Invest. 106: R49-R58 [Medline].
6. Enelow, R. I., A. Z. Mohammed, M. H. Stoler, J. S. Young, Y. H. Lou, and T. J. Braciale. 1998. Experimental T cell-mediated lung disease: structural and functional consequences of alveolar cell recognition by CD8+ T lymphocytes. J. Clin. Invest. 102: 1653-1661 [Medline].
7.
Liu, A. N.,
A. Z. Mohammed,
W. R. Rice,
D. T. Fiedelday,
J. S. Liebermann,
J. A. Whitsett,
T. J. Braciale, and
R. I. Enelow.
1999.
Perforin-independent cytotoxicity in T cell-mediated cytotoxicity of alveolar epithelial cells is
preferentially mediated by tumor necrosis factor-
: relative insensitivity to Fas
ligand.
Am. J. Respir. Cell Mol. Biol.
20:
849-858
8.
Kinkhabwala, M.,
P. Sehajpal,
E. Skolnik,
D. Smith,
V. K. Sharma,
H. Vlassara,
A. Cerami, and
M. Suthanthiran.
1990.
A novel addition to the T cell
repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells.
J. Exp. Med.
171:
941-946
9. Kusters, S., G. Tiegs, L. Alexopoulou, M. Pasparakis, E. Douni, G. Kinstle, H. Bluethmann, A. Wendel, K. Pfizenmaier, G. Kollias, and M. Grell. 1997. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol. 11: 2870-2875 .
10. Kriegler, M., C. Perez, K. DeFay, I. Albert, and S. D. Lu. 1988. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53: 45-53 [Medline].
11. Graham, M., T. Braciale, and V. Braciale. 1996. Use of antiviral T-lymphocyte clones to characterize antigen presentation and T-lymphocyte subsets. Methods: A Companion to Methods Enzymol. 9:439-444.
12.
Walsh, C.,
M. Matloubian,
C. Lui,
R. Udea,
C. Kurahara,
J. Christiansen,
M. Huang,
J. Young,
R. Ahmed, and
W. Clark.
1994.
Immune function in mice
lacking the perforin gene.
Proc. Natl. Acad. Sci. USA
91:
10854-10858
13. Enelow, R., M. Stoler, A. Srikiatkhachorn, C. Kerlakian, S. Agersborg, J. Whitsett, and T. Braciale. 1996. A lung-specific neo-antigen elicits specific CD8+ T cell tolerance with preserved CD4+ T cell reactivity. J. Clin. Invest. 98: 914-922 [Medline].
14. Corti, M., A. R. Brody, and J. H. Harrison. 1996. Isolation and primary culture of murine alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 14: 309-315 [Abstract].
15. Ada, G., and P. Jones. 1987. The cell-mediated and humoral responses to influenza virus infection in the mouse lung. Adv. Exp. Med. Biol. 216B:1033-1042.
16.
Braciale, T. J., and
K. L. Yap.
1978.
Role of viral infectivity in the induction
of influenza virus-specific cytotoxic T cells.
J. Exp. Med.
147:
1236-1252
17. Braciale, V. 1993. CD4+ and CD8+ cytolytic T lymphocyte recognition of viral antigens. In Cytotoxic Cells. Vol. 1. M. Sitkovsky, and P. Henkart, editors. Birkhauser, Boston. 3528-3365.
18. Braciale, T. J., and V. L. Braciale. 1992. Viral antigen presentation and MHC assembly. Semin. Immunol. 4: 81-84 [Medline].
19. Kuwano, K., N. Hagimoto, M. Kawasaki, T. Yatomi, N. Nakamura, S. Nagata, T. Suda, R. Kunitake, T. Maeyama, H. Miyazaki, and N. Hara. 1999. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest. 104: 13-19 [Medline].
20. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369: 31-37 [Medline].
21. Berke, G., D. Rosen, and D. Ronen. 1993. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes. Immunology 78: 105-112 [Medline].
22. Cao, W., S. S. Tykodi, M. T. Esser, V. L. Braciale, and T. J. Braciale. 1995. Partial activation of CD8+ T cells by a self-derived peptide. Nature 378: 295-298 [Medline].
23.
Brossart, P., and
M. J. Bevan.
1996.
Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide.
J. Exp. Med.
183:
2449-2458
24. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27 [Medline].
25.
Fiedler, M. A.,
K. Wernke-Dollries, and
J. M. Stark.
1995.
Respiratory syncytial virus increases IL-8 gene expression and protein release in A549
cells.
Am. J. Physiol.
269:
L865-L872
26.
Biron, C. A..
1999.
Initial and innate responses to viral infections
pattern
setting in immunity or disease.
Curr. Opin. Microbiol.
2:
374-381
.
[Medline]
27.
Selin, L. K.,
S. M. Varga,
I. C. Wong, and
R. M. Welsh.
1998.
Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations.
J. Exp. Med.
188:
1705-1715
28. Flynn, K. J., G. T. Belz, J. D. Altman, R. Ahmed, D. L. Woodland, and P. C. Doherty. 1998. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8: 683-691 [Medline].
29. Muller, C., and J. Tschopp. 1994. Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin. J. Immunol. 153: 2470-2478 [Abstract].
30.
Bird, C. H.,
V. R. Sutton,
J. Sun,
C. E. Hirst,
A. Novak,
S. Kumar,
J. A. Trapani, and
P. I. Bird.
1998.
Selective regulation of apoptosis: the cytotoxic
lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway.
Mol.
Cell Biol.
18:
6387-6398
31.
Sun, J.,
C. H. Bird,
V. Sutton,
L. McDonald,
P. B. Coughlin,
T. A. De Jong,
J. A. Trapani, and
P. I. Bird.
1996.
A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is
present in cytotoxic lymphocytes.
J. Biol. Chem.
271:
27802-27809
32. Chensue, S., K. Warmington, N. Lukacs, P. Lincoln, M. Burdick, R. Strieter, and S. Kunkel. 1995. Monocyte chemotactic protein expression during schistosome egg granuloma formation. Sequence of production, localization, contribution, and regulation. Am. J. Pathol. 146: 130-138 [Abstract].
33.
Agostini, C.,
M. Cassatella,
R. Zambello,
L. Trentin,
S. Gasperini,
A. Perin,
F. Piazza,
M. Siviero,
M. Facco,
M. Dziejman,
M. Chilosi,
S. Qin,
A. D. Luster, and
G. Semenzato.
1998.
Involvement of the IP-10 chemokine in sarcoid granulomatous reactions.
J. Immunol.
161:
6413-6420
34. Keane, M. P., D. A. Arenberg, J. P. Lynch III, R. I. Whyte, M. D. Iannettoni, M. D. Burdick, C. A. Wilke, S. B. Morris, M. C. Glass, B. DiGiovine, S. L. Kunkel, and R. M. Strieter. 1997. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J. Immunol. 159: 1437-1443 [Abstract].
35.
Keane, M. P.,
J. A. Belperio,
T. A. Moore,
B. B. Moore,
D. A. Arenberg,
R. E. Smith,
M. D. Burdick,
S. L. Kunkel, and
R. M. Strieter.
1999.
Neutralization of
the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.
J. Immunol.
162:
5511-5518
36.
Keane, M. P.,
J. A. Belperio,
D. A. Arenberg,
M. D. Burdick,
Z. J. Xu,
Y. Y. Xue, and
R. M. Strieter.
1999.
IFN-gamma-inducible protein-10 attenuates
bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis.
J. Immunol.
163:
5686-5692
37.
Hogaboam, C. M.,
N. W. Lukacs,
S. W. Chensue,
R. M. Strieter, and
S. L. Kunkel.
1998.
Monocyte chemoattractant protein-1 synthesis by murine lung
fibroblasts modulates CD4+ T cell activation.
J. Immunol.
160:
4606-4614
38. Smith, R., R. Streiter, S. Phan, and S. Kunkel. 1996. C-C chemokines: novel mediators of the profibrotic response to bleomycin challenge. Am. J. Respir. Cell Mol. Biol. 15: 693-702 [Medline].
39.
Kagi, D.,
F. Vignaux,
B. Ledermann,
K. Burki,
V. Depraetere,
S. Nagata,
H. Nengartner, and
P. Golstein.
1994.
Fas and perforin as major mechanisms
of T cell-mediated cytotoxicity.
Science
265:
528-530
40. Walsh, C. M., A. A. Glass, V. Chiu, and W. R. Clark. 1994. The role of the Fas lytic pathway in a perforin-less CTL hybridoma. J. Immunol. 153: 2506-2514 [Abstract].
41. Topham, D. J., R. A. Tripp, and P. C. Doherty. 1997. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J. Immunol. 159: 5197-5200 [Abstract].
42. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 Kda tumor necrosis factor receptor. Cell 83: 793-802 [Medline].
43. Pimentel-Muinos, F. X., and B. Seed. 1999. Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity 11: 783-793 [Medline].
This article has been cited by other articles:
![]() |
E. G. Tzortzaki and N. M. Siafakas A hypothesis for the initiation of COPD Eur. Respir. J., August 1, 2009; 34(2): 310 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Pryhuber, H. L. Huyck, S. Bhagwat, M. A. O'Reilly, J. N. Finkelstein, F. Gigliotti, and T. W. Wright Parenchymal Cell TNF Receptors Contribute to Inflammatory Cell Recruitment and Respiratory Failure in Pneumocystis carinii-Induced Pneumonia J. Immunol., July 15, 2008; 181(2): 1409 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nikos "In the Beginning" of COPD: Is Evolution Important? Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 423 - 424. [Full Text] [PDF] |
||||
![]() |
J. Liu, M. Q. Zhao, L. Xu, C. V. Ramana, W. Declercq, P. Vandenabeele, and R. I. Enelow Requirement for Tumor Necrosis Factor-Receptor 2 in Alveolar Chemokine Expression Depends upon the Form of the Ligand Am. J. Respir. Cell Mol. Biol., November 1, 2005; 33(5): 463 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Hildebrandt, K. M. Olkiewicz, L. A. Corrion, Y. Chang, S. G. Clouthier, C. Liu, and K. R. Cooke Donor-derived TNF-{alpha} regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation Blood, July 15, 2004; 104(2): 586 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Hildebrandt, U. A. Duffner, K. M. Olkiewicz, L. A. Corrion, N. E. Willmarth, D. L. Williams, S. G. Clouthier, C. M. Hogaboam, P. R. Reddy, B. B. Moore, et al. A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation Blood, March 15, 2004; 103(6): 2417 - 2426. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yokohori, K. Aoshiba, and A. Nagai Increased Levels of Cell Death and Proliferation in Alveolar Wall Cells in Patients With Pulmonary Emphysema Chest, February 1, 2004; 125(2): 626 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Vanderbilt, E. M. Mager, L. Allen, T. Sawa, J. Wiener-Kronish, R. Gonzalez, and L. G. Dobbs CXC Chemokines and Their Receptors Are Expressed in Type II Cells and Upregulated following Lung Injury Am. J. Respir. Cell Mol. Biol., December 1, 2003; 29(6): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Olman and M. A. Matthay Transforming growth factor-{beta} induces fibrosis in immune cell-depleted lungs Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L522 - L526. [Full Text] [PDF] |
||||
![]() |
K. Aoshiba, N. Yokohori, and A. Nagai Alveolar Wall Apoptosis Causes Lung Destruction and Emphysematous Changes Am. J. Respir. Cell Mol. Biol., May 1, 2003; 28(5): 555 - 562. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |